Risk higher despite lower infection risk and regardless of sociodemographic and medical factors
mRNA-1273 Continues to Be Efficacious at Five Months
Vaccine efficacy was 93.2 percent for preventing COVID-19 illness, 98.2 percent for preventing severe COVID-19
Highest Parental COVID-19 Vaccine Hesitancy Seen Among Most Impacted
Black parents and those of publicly insured children show greatest vaccine hesitancy
Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers
Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic
Pfizer to Ask FDA Soon for Approval of Its COVID-19 Vaccine for Younger Children
Right now, COVID-19 vaccines are only approved for children 12 years and older